Copyright
©The Author(s) 2017.
World J Cardiol. Jun 26, 2017; 9(6): 481-495
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.481
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.481
Test | High risk criteria |
Electrocardiogram | Presence of LV hypertrophy with secondary ST segment deviation ("LV strain") |
Blood tests | Highly increased BNP/Nt-ProBNP levels |
Stress test | Unmasked symptoms: Fatigability/dyspnea at < 75 W, syncope/near syncope; angina |
Lack of increase in systolic blood pressure by > 20 mmHg (or decrease) with exercise | |
Inducible myocardial ischemia (ST segment depression ≥ 2 mm) | |
Severe ventricular arrhythmias (sustained VT, polymorphic VT, VF) | |
Conventional Doppler echocardiography | Very severe AS (AVA ≤ 0.6 cm; maximal velocity ≥ 5 m/s) |
LVEF < 50% | |
Severe LV hypertrophy (≥ 15 mm)? | |
Reduced LV longitudinal strain | |
Zva ≥ 4.5 mmHg/mL per square meters | |
Dobutamine stress echocardiography (in low-flow, low-gradient, low LVEF) | Lack of contractile reserve |
Exercise echocardiography (ergometric bicycle) - any severe AS | Increase in transvalvular pressure gradient by > 20 mmHg during exercise |
Inducible pulmonary hypertension during exercise (systolic pulmonary pressure ≥ 60 mmHg) | |
Documentation of valvular calcification | Presence of severe valvular calcifications: Qualitatively (radiology, conventional echocardiography); quantitatively (computed tomography): Calcium score ≥ 1651 Agatston units (lower in women vs men) |
- Citation: Mǎrgulescu AD. Assessment of aortic valve disease - a clinician oriented review. World J Cardiol 2017; 9(6): 481-495
- URL: https://www.wjgnet.com/1949-8462/full/v9/i6/481.htm
- DOI: https://dx.doi.org/10.4330/wjc.v9.i6.481